Category: Federal False Claims Act

SEC Adopts Final Regulations for Whistleblower Program

With great anticipation, the SEC adopted its final regulations governing the new whistleblower program under the Dodd-Frank financial reform legislation.  Most significantly, the SEC did away with a proposed requirement that whistleblowers first report wrongdoing internally before reporting to the SEC, despite strong opposition from corporate lobbyists.  The SEC did provide enhanced remedies for whistleblowers that decide to first report internally by reaffirming that such whistleblowers will still be eligible for an award,

Allegheny County Surfs the False Claims Wave

Allegheny County, Pennsylvania became  the first  municipal government in Pennsylvania and the fourth nationwide to adopt a false claims act.  The new ordinance, based generally on the Federal False Claims Act allows a private individual to file a complaint for false claims after the county Solicitor has investigated the allegations of the complaint and declined to intervene. 

Mortgage Firms Accused of Defrauding Taxpayers

According to a report in the Huffington Post, recent confidential federal audits accuse the nation’s five largest mortgage companies of defrauding taxpayers in their handling of foreclosures on homes purchased with government-backed loans.  Five separate investigations conducted by the Department of Housing and Urban Development’s inspector general examined Bank of America,

Supreme Court says FOIA Response is a Bar to Qui Tam Suit

In Schindler Elevator v. United States ex rel. Kirk, the United States Supreme Court held that a federal agency’s written response to a FOIA request for records constitutes a “report” within the meaning of the False Claims Act’s public disclosure bar.  The Court looked to the dictionary definition for “report”,

IRS Withholding Taxes from Whitleblower Rewards

Changes to the law in 2006 guaranteed whistleblowers between 15 and 30 percent of any IRS recovery based upon information provided by a whistleblower.  More recent changes guarantee that the IRS receives its cut of these whistleblower payouts.  The IRS has announced that it intends to withhold taxes from the whistleblower award payments that it makes. 

DOJ Settlement with ABN AMRO Mortgage Group, Inc.

United States Attorney Stephen J. Murphy and the Department of Justice announced that ABN AMRO Mortgage Group, Inc. (ABN) has agreed upon a settlement with the United States government valued at over $41 million evolving from a False Claims Act case in connection with over 28,000 federally insured mortgages. This payment by ABN is one of the largest ever acquired in a civil settlement by the U.S.

Shell to Pay $2.3 Million to the U.S. Government

The United State Department of Justice has announced that Shell Oil Company, Shell Offshore Inc., Shell Frontier Oil & Gas Inc., and Shell Western Exploration and Production have come to an agreement regarding the False Claims Act charges filed against them. The Shell Defendants will pay the United States $2.2 million plus interest to resolve claims that the Shell companies violated the False Claims Act by deliberately underpaying royalties owed on natural gas produced from Federal leases.

Dyncorp International LLC and The Sandi Group to Pay $8.7 Million to the U.S. Government

Dyncorp International LLC and its subcontractor, The Sandi Group, were charged with allegations of submitting false claims for payment under Dyncorp’s contract with the Department of State to provide civilian police training in Iraq.  The qui tam lawsuit was filed by two former TSG employees, which alleged that Dyncorp was submitting inflated claims for the construction of container camps at various locations in Iraq and that TSG was seeking reimbursement for danger pay that it falsely claimed to have paid its U.S.

Masoncare settles for $450,000 in Medicare/Medicaid False Claims Act Violation

Masoncare Health Center, an inpatient and outpatient healthcare facility, was charged with violating the False Claims Act and will pay the government almost $450,000 to resolve the allegations.  Masoncare was improperly billing Medicare and Medicaid for injections of leuprolide acetate, or Lupron.  The medication is used to treat prostate cancer in men and endometriosis and fibroids in women.

Contact one of our

Experienced Attorneys

If you are aware of any person, corporation or entity that you think may be violating the Federal False Claims Act or a State False Claims Act, contact us today.

CONTACT US